Dialyvite Supreme D
NDC 10542-009, Ascorbic Acid, Cholecalciferol, Alpha-Tocopherol, Thiamine, Riboflavin, Niacinamide, Pyridoxine, Folic Acid, Cobalamin, Biotin, Pantothenic Acid, Zinc, Selenium, tablet, coated, from Hillestad Pharmaceuticals USA.
- Product NDC
- 10542-009
- Status
- Listed
- Labeler
- Hillestad Pharmaceuticals USA
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10542-009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ASCORBIC ACID100 mg/1
- CHOLECALCIFEROL2000 [iU]/1
- .ALPHA.-TOCOPHEROL SUCCINATE, D-30 [iU]/1
- THIAMINE MONONITRATE1.5 mg/1
- RIBOFLAVIN1.7 mg/1
- NIACINAMIDE20 mg/1
- PYRIDOXINE HYDROCHLORIDE25 mg/1
- FOLIC ACID3 mg/1
- COBALAMIN1 mg/1
- BIOTIN300 ug/1
- CALCIUM PANTOTHENATE10 mg/1
- ZINC CITRATE15 mg/1
- SELENOCYSTEINE70 ug/1
Pharmacologic classes
Analogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Vitamin B 6 [Chemical/Ingredient]; Vitamin B6 Analog [EPC]; Vitamin C [EPC]; Vitamin D [CS]; Vitamin D [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10542-009-02 | 10542000902 | 7 TABLET, COATED in 1 BOTTLE, PLASTIC (10542-009-02) |
| 10542-009-09 | 10542000909 | 90 TABLET, COATED in 1 BOTTLE, PLASTIC (10542-009-09) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/46fc3acf-1e6d-4830-ae9a-abd9c1132fcaNADAC price for package 10542000909
GET /v1/drugs/nadac/10542000909
Use it
Look up 10542-009 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10542-009 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10542-009. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.